ENDPOINTS

Immunic’s stock falls on multiple sclerosis data; Entrada’s layoffs

Plus, news about Henlius, Sandoz, Cellectar Biosciences, Ono Pharma and Altamira Therapeutics: Immunic’s Phase 2 multiple sclerosis readout: The company said vidofludimus calcium (IMU-838) reduced the relative risk of disease worsening ...

Apr 30, 2025 - 15:45
 0
Immunic’s stock falls on multiple sclerosis data; Entrada’s layoffs
Plus, news about Henlius, Sandoz, Cellectar Biosciences, Ono Pharma and Altamira Therapeutics: Immunic’s Phase 2 multiple sclerosis readout: The company said vidofludimus calcium (IMU-838) reduced the relative risk of disease worsening ...
Read More

Tags:

Previous Article

10 wise remarks overheard at Circularity 25

Next Article

Why clean energy is key to building a more resilient future in uncertain times

Related Posts

WuXi AppTec sees revenue growth after 2024’s decline

WuXi AppTec sees revenue growth after 2024’s decline

Apr 28, 2025  0

Amgen invests $900M to expand Ohio biomanufacturing

Amgen invests $900M to expand Ohio biomanufacturing

Apr 25, 2025  0

Genentech vet launches ADC startup with $20M

Genentech vet launches ADC startup with $20M

Apr 23, 2025  0